Related Experiment Video
Updated: May 11, 2026
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Murine interleukin-4 displays potent anti-tumor activity in vivo
R I Tepper1, P K Pattengale, P Leder
1Department of Genetics, Harvard Medical School, Boston, Massachusetts.
Abstract:
We have devised a sensitive means to assess the anti-tumor effect of cytokines that act via the mobilization of host-mediated defenses. This assay involves transfecting malignant cells to produce a specific cytokine (in this case, IL-4) and measuring the ability of transfectants to form tumors alone and when mixed with a variety of nontransfected tumor cells. In this way, we have identified a potent, non-cell autonomous, anti-tumor effect of IL-4 which is effective against a wide range of tumor cell types in vivo. The effect is reversed by anti-IL-4 antibody, correlates closely with levels of IL-4 production, and is evident in nu/nu mice. The anti-tumor effect seems to be mediated by an inflammatory infiltrate composed of eosinophils and macrophages.
Insights
Interleukin-4 (IL-4) demonstrates a potent anti-tumor effect by mobilizing host defenses. This cytokine therapy shows promise against various cancers by recruiting eosinophils and macrophages to fight tumors.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Cytokines are crucial for immune responses and can influence tumor growth.
- Understanding cytokine-mediated anti-tumor effects is vital for developing novel cancer therapies.
Purpose of the Study:
- To develop a sensitive assay for assessing cytokine-induced anti-tumor immunity.
- To investigate the anti-tumor efficacy of Interleukin-4 (IL-4) via host-mediated defenses.
Main Methods:
- Transfecting tumor cells to produce specific cytokines (IL-4).
- Assessing tumor formation in vivo with cytokine-producing transfectants alone and co-cultured with non-transfected tumor cells.
- Evaluating the effect of anti-IL-4 antibodies and analyzing inflammatory infiltrates.
Main Results:
- Identified a potent, non-cell autonomous anti-tumor effect of IL-4 effective against diverse tumor types in vivo.
- Demonstrated that the anti-tumor effect is reversed by anti-IL-4 antibody and correlates with IL-4 production levels.
- Observed the anti-tumor effect in immunodeficient nu/nu mice, suggesting a role for inflammatory cells.
Conclusions:
- IL-4 exhibits significant therapeutic potential as an anti-cancer agent through host-mediated immune responses.
- The anti-tumor activity of IL-4 is mediated by an inflammatory infiltrate, including eosinophils and macrophages.
- The developed assay provides a sensitive platform for evaluating cytokine-based anti-tumor strategies.
